September 7, 2022 — Nuwellis, Inc., a commercial-stage company focused on transforming the lives of people with fluid ...
September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press ...
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and ...
September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...
September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...
September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...
September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...
September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including ...
September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by ...
September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ...
September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...
September 07, 2022
